Markets:

Overview

News

Currencies

International

Treasuries

Twist Bioscience Corporation - Common Stock (NQ:TWST)

49.12 +1.63 (+3.44%)

Streaming Delayed Price Updated: 2:57 PM EDT, Mar 25, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Twist Bioscience Corporation - Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

C2i Genomics Partners with Twist Bioscience to Launch Reference Materials for Whole-Genome Cancer Detection

February 08, 2022

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience, Eleven Therapeutics Create Synthetic Viral RNA Molecules To Develop Antiviral Vaccines, Therapeutics ↗

February 07, 2022

Twist Bioscience Corp (NASDAQ: TWST) and Eleven Therapeutics have created a replicon tool that could be used for studying viral genome replication, antiviral drug...

Via Benzinga

Twist Bioscience and Eleven Therapeutics Create Replicon for Development of Antiviral Tools

February 07, 2022

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Clocks ~50% Jump In Q1 Sales, Lifts FY22 Revenue Guidance ↗

February 04, 2022

Twist Bioscience Corp (NASDAQ: TWST) reported a

Via Benzinga

Recap: Twist Bioscience Q1 Earnings ↗

February 04, 2022

Twist Bioscience (NASDAQ:TWST) reported its Q1 earnings results on Friday, February 4, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Via Benzinga

The Daily Biotech Pulse: Sanofi, Bristol-Myers Squibb Gain On Earnings, Valneva-Pfizer Tout Positive Lyme Disease Vaccine Data, UNITY Biotech Restructures ↗

February 04, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

Twist Bioscience Reports First Quarter 2022 Financial Results

February 04, 2022

From Twist Bioscience Corporation

Via Business Wire

Earnings Scheduled For February 4, 2022 ↗

February 04, 2022

Companies Reporting Before The Bell • Brookfield Business (NYSE:BBU) is estimated to report earnings for its fourth quarter.

Via Benzinga

Earnings Outlook For Twist Bioscience ↗

February 03, 2022

Twist Bioscience (NASDAQ:TWST) is set to give its latest quarterly earnings report on Friday, 2022-02-04. Here's what investors need to know before the announcement. Analysts estimate that Twist...

Via Benzinga

Abcam Collaborates With Twist Bioscience to Enhance Antibody Discovery for Diagnostic and Research Applications

February 01, 2022

From Twist Bioscience Corporation

Via Business Wire

The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News ↗

January 31, 2022

The broader market weakness pervaded into the biotech sector in the week ending Jan. 28, sending stocks lower.

Via Benzinga

Twist Bioscience Releases Inaugural ESG Report Highlighting Achievements and Initiatives in Diversity and Sustainability

January 31, 2022

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Signs Collaboration with Artisan Bio to Engineer Next Generation Cell Therapeutics

January 25, 2022

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience to Report Fiscal 2022 First Quarter Financial Results on Friday, February 4, 2022

January 20, 2022

From Twist Bioscience Corporation

Via Business Wire

Stocks That Hit 52-Week Lows On Friday ↗

January 14, 2022

During Friday's session, 445 companies made new 52-week lows. Noteable 52-Week Lows: Intuitive Surgical (NASDAQ:ISRG) is the largest company in terms of market cap to...

Via Benzinga

Twist Bioscience’s Comprehensive DNA Synthesis Capabilities Expanded as Industry-Leading Enzymatic Synthesis Process Unveiled at Annual J.P. Morgan Healthcare Conference

January 10, 2022

From Twist Bioscience Corporation

Via Business Wire

Stocks That Hit 52-Week Lows On Thursday ↗

January 06, 2022

On Thursday, 615 stocks hit new 52-week lows. Noteable 52-Week Lows: Sea (NYSE:SE) is the largest company in terms of market cap to set a new 52-week low this...

Via Benzinga

Twist Bioscience Creates Custom Whole Exome Target Enrichment Panel for Canine Genomic Research

January 06, 2022

From Twist Bioscience Corporation

Via Business Wire

Revelar Biotherapeutics and Twist Bioscience Announce RBT-0813 Neutralizes SARS-CoV-2 Omicron (B.1.1.529/BA.1) and Delta (B.1.617.2) Variants

January 05, 2022

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience to Present at the 40th Annual J.P. Morgan Healthcare Conference

January 04, 2022

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Launches 96-Plex Library Prep Kit for Low Pass High Throughput Next-Generation Sequencing

December 20, 2021

From Twist Bioscience Corporation

Via Business Wire

Sosei Heptares Enters Antibody Discovery Agreement with Twist Bioscience to Discover and Develop Novel Therapeutic Antibodies Against GPCR Targets

December 16, 2021

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Now Shipping Synthetic RNA Positive Controls for Omicron (B.1.1.529/BA.1) SARS-CoV-2 Variant for Development of Accurate Diagnostic Tests

December 15, 2021

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Launches Circulating Tumor DNA Reference Controls for Development of Liquid Biopsy Assays

December 07, 2021

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Announces Participation in SRC-SIA Webinar on the Decadal Plan for Semiconductors

November 30, 2021

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience to Present at Upcoming Virtual Conferences

November 24, 2021

From Twist Bioscience

Via Business Wire

Why Are Twist Bioscience Shares Plunging Today? ↗

November 22, 2021

Twist Bioscience Corporation (NASDAQ: TWST) reported a 17% Y/Y increase in its Q4 revenues to $37.95 million, beating the Wall Street estimate of $37.02 million, driven...

Via Benzinga

Twist Bioscience Reports Fourth Quarter and Full Year Fiscal 2021 Financial Results

November 22, 2021

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Enters into Definitive Agreement to Acquire Abveris, Bolstering Biopharma Capabilities

November 22, 2021

From Twist Bioscience Corporation

Via Business Wire

Earnings Scheduled For November 22, 2021 ↗

November 22, 2021

Companies Reporting Before The Bell • Cerence (NASDAQ:CRNC) is estimated to report quarterly earnings at $0.56 per share on revenue of $97.92 million. • Avaya...

Via Benzinga

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.